Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 102.05

+0.3%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (1430)	4/25/2000 9:38:00 PM
From: Spekulatius	Read Replies (1) of 3202

INCY topline growth - I am not quite sure if I can share the optimism in this thread. My major concern is that INCY revenue growth was less than 10% compared to 1999. INCY revenue stood at 40.7M$ versus 37M$ last year. With all the euphoria about genomics, why are INCY customers not paying for it? Is this due to LT contracts,intense competition, a shift from a subcription to a royalty (deferred) based compensation ? I feel this will be critical to evaluate INCY as an investment.I sure like that they have close to 700M$ in cash.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next